Report overview
Diabetes software can include aggregate and analytical views of diabetes data. These views include:
? Calendar views that display glucose trends and compare them to patient?s insulin intake.
? Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
? Listing of contextual and lifestyle data such as patient?s carb intake.
? Insulin data that includes pie charts showing the ratio of basal to bolus rates.
? General data tables that show average blood glucose rates bucketed into different time periods
? And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
This report aims to provide a comprehensive presentation of the global market for Diabetes Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Software. This report contains market size and forecasts of Diabetes Software in global, including the following market information:
Global Diabetes Software Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
For Smartphones Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Software include Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd, Abbott Diabetes Care and Acon Diabetes Care International, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Software Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Diabetes Software Market Segment Percentages, by Type, 2022 (%)
For Smartphones
For Tablet PC
Web-based
Global Diabetes Software Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Diabetes Software Market Segment Percentages, by Application, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Diabetes Software Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Diabetes Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Software revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Software, market overview.
Chapter 2: Global Diabetes Software market size in revenue.
Chapter 3: Detailed analysis of Diabetes Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
